It remains to be clarified whether a positive sentinel lymph node biopsy (SLNB) can predict
the number of metastatic axillary nodes. This study examined a consecutive series of women …

Background: It is unclear which breast cancer patients with positive sentinel lymph nodes
(SLNs) require a completion axillary lymph node dissection. Our aim was to determine …

The next step of sentinel lymph node biopsy (SLNB) in breast cancer is to determine which
patients need axillary lymph node dissection (ALND) following a positive SLNB. A …

Objective The aim of the present study was to determine how many sentinel lymph nodes
(SLNs) are appropriate for predicting non-SLN metastasis in breast cancer. Methods The …

Abstract Background: Sentinel Lymph Node Biopsy (SLNB) procedure was found to be an
accurate method of staging the axilla in patients with early stage breast cancer. The …

Purpose: The negative sentinel lymph node (SLN) biopsy avoids conventional axillary
dissection in patients with breast cancer with clinically negative axilla. Despite negative …

BACKGROUND: Sentinel lymph node (SLN) biopsy examination is the current modality for
evaluating the axilla in breast cancer patients. A nomogram has been developed to predict …

Background: Several clinical trials are re-evaluating the management of the axilla after
sentinel node (SN) biopsy. Approximately 50–70% of patients with positive SN have no …

In many patients, the sentinel lymph node (SLN) is the sole site of regional nodal metastasis.
This subgroup of patients would not be expected to benefit from completion axillary lymph …

Since the routine clinical use of the sentinel lymph node (SLN) procedure, questions have
been raised concerning an increase in the overall percentage of node-positive patients. The …